These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 3243884)
21. Determination of foscarnet (trisodium phosphonoformate) in pharmaceutical preparations by high-performance liquid chromatography with ultraviolet detection. García J; Márquez A; Ruiz R; López LF; Claro C; Lucero MJ Biomed Chromatogr; 2006 Oct; 20(10):1024-7. PubMed ID: 16583452 [TBL] [Abstract][Full Text] [Related]
22. [Indirect spectrophotometric detection by reversed-phase liquid chromatography. Application in drug analysis]. Herne P J Pharm Belg; 1990; 45(2):151-9. PubMed ID: 2192023 [TBL] [Abstract][Full Text] [Related]
23. Determination of meglumine in pharmaceutical formulations using high performance liquid chromatography. Jasprica I; Mrsić N; Dragić T; Cetina-Cizmek B Pharmazie; 2011 Dec; 66(12):916-9. PubMed ID: 22312693 [TBL] [Abstract][Full Text] [Related]
24. Separation of proteins by reversed-phase high-performance liquid chromatography. II. Optimizing sample pretreatment and mobile phase conditions. Nugent KD; Burton WG; Slattery TK; Johnson BF; Snyder LR J Chromatogr; 1988 Jun; 443():381-97. PubMed ID: 3049650 [TBL] [Abstract][Full Text] [Related]
25. A comparison of silica and alumina columns for high-performance liquid chromatographic separations of basic drugs and plasma constituents following on-line solid-phase extraction with column switching. Kelly MT; Smyth MR J Pharm Biomed Anal; 1989; 7(12):1757-64. PubMed ID: 2490564 [TBL] [Abstract][Full Text] [Related]
26. Impurity profile tracking for active pharmaceutical ingredients: case reports. Zhou L; Mao B; Reamer R; Novak T; Ge Z J Pharm Biomed Anal; 2007 Jun; 44(2):421-9. PubMed ID: 17142001 [TBL] [Abstract][Full Text] [Related]
27. Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form. den Brok MW; Nuijen B; Hillebrand MJ; Grieshaber CK; Harvey MD; Beijnen JH J Pharm Biomed Anal; 2005 Sep; 39(1-2):46-53. PubMed ID: 15899571 [TBL] [Abstract][Full Text] [Related]
28. Single column comprehensive analysis of pharmaceutical preparations using dual-injection mixed-mode (ion-exchange and reversed-phase) and hydrophilic interaction liquid chromatography. Kazarian AA; Taylor MR; Haddad PR; Nesterenko PN; Paull B J Pharm Biomed Anal; 2013 Dec; 86():174-81. PubMed ID: 24001905 [TBL] [Abstract][Full Text] [Related]
29. Technical considerations in the use of "high-performance" liquid chromatography in therapeutic drug monitoring. Giese RW Clin Chem; 1983 Jul; 29(7):1331-43. PubMed ID: 6345027 [TBL] [Abstract][Full Text] [Related]
30. Chromatographic column evaluation for the untargeted profiling of glucosinolates in cauliflower by means of ultra-high performance liquid chromatography coupled to high resolution mass spectrometry. Capriotti AL; Cavaliere C; La Barbera G; Montone CM; Piovesana S; Zenezini Chiozzi R; Laganà A Talanta; 2018 Mar; 179():792-802. PubMed ID: 29310309 [TBL] [Abstract][Full Text] [Related]
31. Characterization of bonded stationary phase performance as a function of qualitative and quantitative chromatographic factors in chaotropic chromatography with risperidone and its impurities as model substances. Čolović J; Rmandić M; Malenović A Anal Bioanal Chem; 2018 Aug; 410(20):4855-4866. PubMed ID: 29770836 [TBL] [Abstract][Full Text] [Related]
32. [Use of high pressure liquid chromatography with diode array detector for detection of drugs in emergency medicine]. Felscher D Beitr Gerichtl Med; 1991; 49():381-6. PubMed ID: 1811527 [TBL] [Abstract][Full Text] [Related]
33. Reversed-phase high-performance liquid chromatographic characterization of acetic acid extracts of the normal and the diabetic human pancreas. Welinder BS; Linde S J Chromatogr; 1991 Jan; 537(1-2):201-17. PubMed ID: 2050780 [TBL] [Abstract][Full Text] [Related]
34. Selected aspects of the development of methods for the analysis of drugs by high performance liquid chromatography. Riley CM Xenobiotica; 1987 Mar; 17(3):365-83. PubMed ID: 3554787 [TBL] [Abstract][Full Text] [Related]
35. Increased productivity in quantitative bioanalysis using a monolithic column coupled with high-flow direct-injection liquid chromatography/tandem mass spectrometry. Huang MQ; Mao Y; Jemal M; Arnold M Rapid Commun Mass Spectrom; 2006; 20(11):1709-14. PubMed ID: 16676309 [TBL] [Abstract][Full Text] [Related]
36. Selection of high-performance liquid chromatographic methods in pharmaceutical analysis. III. Method validation. Szepesi G; Gazdag M; Mihályfi K J Chromatogr; 1989 Mar; 464(2):265-78. PubMed ID: 2542347 [TBL] [Abstract][Full Text] [Related]
37. Chemometrics in pharmaceutical analysis. Berridge JC; Jones P; Roberts-McIntosh AS J Pharm Biomed Anal; 1991; 9(8):597-604. PubMed ID: 1790179 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of electron capture detection in reversed-phase HPLC for pharmaceutical analysis. Pereira AS; Szucs R; Sandra P J Sep Sci; 2009 Jan; 32(1):29-33. PubMed ID: 19051192 [TBL] [Abstract][Full Text] [Related]
39. Development of LC chiral methods for neutral pharmaceutical related compounds using reversed phase and normal phase liquid chromatography with different types of polysaccharide stationary phases. Zhou L; Welch C; Lee C; Gong X; Antonucci V; Ge Z J Pharm Biomed Anal; 2009 May; 49(4):964-9. PubMed ID: 19299098 [TBL] [Abstract][Full Text] [Related]
40. Secondary isotope effects in liquid chromatography behaviour of 2H and 3H labelled solutes and solvents. Valleix A; Carrat S; Caussignac C; Léonce E; Tchapla A J Chromatogr A; 2006 May; 1116(1-2):109-26. PubMed ID: 16631181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]